Sign up to save your podcasts
Or
Share Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors
Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.
View all episodes
By Springer HealthcareCristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.